10Indications and Pitfalls of Glass Ionomer and HA Cement

FWhat bone cement is, and what it is for

Most ossiculoplasty is about replacing a missing strut: a prosthesis or an autograft is slotted in to carry sound from the drum to the footplate. Bone cement answers a narrower, more specific problem. It is a mouldable paste that the surgeon applies directly across a gapin the ossicular chain and that then hardens in place, gluing the two remnants back into a continuous lever. There is no free prosthesis to position, crimp, or watch for extrusion — the reconstruction becomes part of the patient’s own ossicles. The classic picture is the eroded long process of the incus: the tip has melted away in chronic otitis media, leaving a small space between a healthy incus body and an intact, mobile stapes. A bead of cement rebuilds the missing few millimetres, and continuity — and hearing — is restored[2005, 2019].

Two materials dominate. Glass ionomer cement (GIC)is a polyalkenoate ceramic, borrowed from dentistry, that sets by an acid–base reaction and bonds chemically to bone. Hydroxyapatite (HA) cementis a calcium-phosphate paste that cures to a material chemically and structurally close to natural bone, with excellent biocompatibility. Both share the same fundamental appeal: they re-establish a rigid, low-mass, continuous connection across a small defect, and both share the same fundamental constraint — they only work when the surgeon obeys a short list of preconditions. This module is about those preconditions: the cases where cement is the elegant answer, and the cases where it is a trap.

FThe ideal case: small gap, dry field, stable remnants

Three conditions define a good cement case, and all three must be present. First, the gap must be small. Cement bridges, it does not build columns. A focal defect of roughly two to three millimetres between two ossicular remnants is its home territory; a long, unsupported span sags and fractures because the cured material has no internal scaffold to carry the load. Second, the field must be dry. Both GIC and HA cement set by chemical reactions that moisture disrupts: blood, mucus, or a thin film of effusion at the interface leaves the cement under-cured and weakly bonded, and the bridge later fails. Third, the remnants must be stable and mobile— cement re-joins two pieces of a chain, so each end needs a solid, mobile anchor, classically a healthy incus body on one side and an intact, mobile stapes on the other.

The widget below lets you vary the bridging distance and see why the span matters: short gaps give a reliable bridge, while the unsupported span beyond a few millimetres sags toward failure. It is the single most important idea in the module — cement is a gap-filler, not a load-bearing strut.

Put the three conditions together and the prototypical case writes itself: a dry, well-aerated middle ear, no active mucosal disease, and a small focal discontinuity at the incudostapedial joint with the stapes superstructure present and mobile. In that ear cement is fast, cheap, and avoids the mass and extrusion concerns of a free prosthesis. Move any one condition the wrong way — a wet field, a large gap, an absent or fixed stapes — and the calculus swings back toward a conventional PORP, TORP, or autograft.

TWhat the evidence shows

Within its niche, cement performs well. In a focused series of forty-eight ears reconstructing incus long-process defects with hydroxyapatite cement, the mean air-bone gap fell from about 21 dB to under 12 dB, and a gap of 20 dB or less was achieved in 83% at middle-term follow-up [2021]. A comparative study set HA bone-cement bridging directly against incus remodelling for incudostapedial discontinuity and found the cement group achieved significantly greaterair-bone-gap gain at six and twelve months, while being faster and technically easier — with no adverse reactions over follow-up[2012]. Glass ionomer rebridging of the same joint has reported air-bone-gap closure in around three-quarters of ears [2005].

The most balanced view comes from a systematic review of bone cement in ossicular reconstruction and revision stapes surgery. Across the pooled studies, air-bone-gap closure to within 20 dB was achieved in 60–94% of patients, and crucially the review found that cement did not underachievecompared with conventional rebridging techniques such as autograft, cartilage, or a prosthesis — while also noting no infection or extrusion in the included ossiculoplasty series[2015]. The honest summary is therefore not that cement is superior, but that for the right small-gap case it is a legitimate, often more convenient equal to the alternatives. Its appeal is practical: a reconstruction so simple it has even been performed transcanal in the office for an isolated incudostapedial erosion, with durable gap closure to six months [2019].

TGlass ionomer versus hydroxyapatite

The two cements are not interchangeable, and the differences steer material choice. Glass ionomerbonds chemically and adhesively to bone, which is part of why it was attractive for fixing a stapes prosthesis to a remnant or rebridging a joint; it has decades of otological use behind it, including large single-centre series spanning up to sixteen years of follow-up [2015]. Its defining liability, discussed in the next section, is its aluminium content, which makes it dangerous in bulk or near cerebrospinal fluid. Hydroxyapatite contains no aluminium, cures to something close to native bone, and has become the more widely favoured cement for routine ossicular work for exactly that reason; the trade-off is that HA pastes can be more demanding to handle and that some are brittle once set.

Two handling realities matter at the operating microscope regardless of material. The first is setting behaviour: a paste that sets too fast leaves no time to shape the bridge, while one that sets too slowly risks displacement before it hardens — products such as the rapidly setting Mimix HA cement were adopted partly because their working and setting times suit the confined middle-ear field [2005]. The second is the absolute requirement for a dry interface, which both cements share and neither forgives. The table summarises the practical contrast.

CThe aluminium story and the nerve pitfall

The single most important safety lesson in this topic came not from ossiculoplasty but from the lateral skull base. When glass ionomer cement was used in large volumesfor mastoid obliteration and posterior canal-wall reconstruction — and, critically, where it could contact cerebrospinal fluid— the aluminium it contains was released as toxic ions. Sentinel case reports in the mid-1990s documented fatal aluminium encephalopathy after otoneurosurgical procedures, with seizures, progressive neurological decline, and death [1994]. These reports effectively ended bulk GIC use in the temporal bone and recast the material as something to be used only in small, focal, dry applications well away from the dura and CSF spaces. The rule that emerged is simple and absolute: cement is never placed in bulk, and never where it can touch CSF.

The second pitfall is closer to the ossiculoplasty field itself: cement against nerve tissue. The eroded ossicular remnant a surgeon wants to rebridge often sits within millimetres of the tympanic segment of the facial nerve, which is frequently dehiscent. Cement is not inert against nerve. In an experimental model applying glass ionomer cement directly to the facial nerve, gross nerve function was preserved over the observation period, but histology showed significantly more foreign-body reaction, granulation tissue, and chronic inflammation than controls [2017]. That chronic reaction is the mechanism behind the clinical warning: cement laid against an exposed nerve can provoke a smouldering inflammatory response. The practical instruction is to confine cement to stable bone and keep it away from any dehiscence; if the only safe placement would abut exposed nerve, choose a different reconstruction.

CA practical routine and the cases to refuse

A workable routine follows directly from the preconditions. First, confirm the indication: a small, focal gap (about 2–3 mm) between two stable, mobile remnants — most often the eroded incudostapedial joint with an intact, mobile stapes [2012, 2021]. Second, prepare the field: clear active disease, secure haemostasis, and dry the interface meticulously, because moisture is the commonest cause of a weak bond. Third, protect the surroundings: identify any facial-nerve dehiscence and keep cement off it, keep the volume minimal, and never let cement near a CSF leak [1994, 2017]. Fourth, apply and shape a small bead across the defect, bridging bone to bone, and allow it to set undisturbed before continuing. Fifth, prefer hydroxyapatite for routine ossicular work given the aluminium liability of glass ionomer[2015].

Equally important is knowing when to refuse cement. Walk away from it when the gap is large or unsupported, when the stapes superstructure is absent (cement cannot build a columella), when the field cannot be made dry, when the remnants are unstable or fixed, and when the only available placement would contact exposed nerve or CSF. In each of those situations a prosthesis or autograft is the safer reconstruction, and the evidence that cement merely equals rather than beats conventional techniques means nothing is lost by choosing them[2015]. Used inside its narrow indication, bone cement is a fast, elegant, low-mass repair; used outside it, it is the source of the very complications — failed bridges and chronic reactions — that gave the material its cautionary reputation.